McLean Hospital

Futó vizsgálatok

• Még nem toboroz

  Pilot Study of Sensor-Informed Smartphone-based Mental Health Interventions for Mood in Early Psychosis

  NCT07503093· Mclean Hospital· Forrás

• Toboroz

  Single Day of Ultra-accelerated TMS With a Single Dose of NRX-101

  NCT07785102· Korai 1. fázis· Mclean Hospital· Forrás

• Toboroz

  Synaptic Mechanisms of Intermittent Theta Burst Stimulation for Major Depressive Disorder

  NCT07593222· 1/2. fázis· Mclean Hospital· Forrás

• Toboroz

  One-Day cTBS Over the Precuneus

  NCT07758010· Mclean Hospital· Forrás

• Toboroz

  Assessing the Mechanisms and Impact of a Novel Cannabinoid Product for Gynecologic Pain

  NCT07728695· 1/2. fázis· Staci Gruber, Ph.D.· Forrás

• Toboroz

  Synaptic Mechanisms of Continuous Theta Burst Stimulation in Depression

  NCT07560878· Korai 1. fázis· Mclean Hospital· Forrás

• Toboroz

  A Study of Brenipatide in Adult Participants With Schizophrenia

  NCT07410507· 2. fázis· Eli Lilly and Company· Forrás

• Toboroz

  Stress Dynamics and Familial Risk for Depression in Female Adolescents

  NCT06816329· Mclean Hospital· Forrás

• Toboroz

  Validation of a Novel Cerebellar-striatal Satiety Circuit in Humans

  NCT06105164· Brigham and Women's Hospital· Forrás

• Fut, nem toboroz

  Sequential Multiple Assignment Randomized Trial for Bipolar Depression

  NCT06433635· 4. fázis· Massachusetts General Hospital· Forrás

• Toboroz

  A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

  NCT06585787· 3. fázis· Karuna Therapeutics, Inc., a Bristol Myers Squibb company· Forrás

• Meghívásos bevonás

  Open Label Extension Study of NCT06221852

  NCT06558201· Mclean Hospital· Forrás

• Toboroz

  Cerebellar Modulation of Cognition in Psychosis

  NCT06107764· Mclean Hospital· Forrás

• Toboroz

  MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction

  NCT06191965· 2/3. fázis· Mclean Hospital· Forrás

• Toboroz

  Ketogenic and Nutritional Interventions for First Episode Bipolar Disorder

  NCT06221852· Mclean Hospital· Forrás

• Fut, nem toboroz

  Evaluating the Impact of a Novel Cannabinoid Product for Endometriosis

  NCT06477406· 2. fázis· Mclean Hospital· Forrás

• Toboroz

  Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder

  NCT06373016· Stony Brook University· Forrás

• Toboroz

  Cerebellar TMS and Satiety in Prader-Willi Syndrome

  NCT05938543· Brigham and Women's Hospital· Forrás

• Toboroz

  Assessing the Impact of Cannabidiol for Anxiety and Depression in Bipolar Disorder

  NCT05457465· 2. fázis· Mclean Hospital· Forrás

• Fut, nem toboroz

  Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD

  NCT05711940· 3. fázis· COMPASS Pathways· Forrás

• Toboroz

  Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

  NCT06740383· Beth Israel Deaconess Medical Center· Forrás

• Toboroz

  Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside

  NCT05245903· Mclean Hospital· Forrás

• Toboroz

  Beyond Monoamines: The Role of the Nociceptin/Orphanin FQ Receptor in Major Depression

  NCT05630963· Mclean Hospital· Forrás

• Toboroz

  Using Transcranial Magnetic Stimulation (TMS) to Understand Hallucinations in Schizophrenia

  NCT05343598· Mclean Hospital· Forrás

• Toboroz

  Neural Correlates of Stress and Perceived Control in Adolescent Depression

  NCT04788524· Mclean Hospital· Forrás

• Fut, nem toboroz

  Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Study 1.2 (Stress Manipulation)

  NCT04325529· Mclean Hospital· Forrás

• Fut, nem toboroz

  Cannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults With Mild Cognitive Impairment or Alzheimer's Dementia

  NCT04075435· Korai 1. fázis· Mclean Hospital· Forrás

• Fut, nem toboroz

  A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease

  NCT03887455· 3. fázis· Eisai Inc.· Forrás

• Fut, nem toboroz

  ERG Components in Schizophrenia and Bipolar Disorder Type I

  NCT03788811· diaMentis Inc.· Forrás

• Fut, nem toboroz

  Low Field Magnetic Stimulation: Imaging Biomarkers in Geriatric Bipolar Depression

  NCT03484494· Mclean Hospital· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Skizofrénia9 toboroz
• Depresszió8 toboroz
• Bipoláris zavar6 toboroz
• Alzheimer-kór2 toboroz
• Elhízás1 toboroz
• Endometriózis1 toboroz

Lezárt vizsgálatok

• Lezárult

  Acute Psychiatric Care at Home for Lower-risk Patients With Acute Psychiatric Illness Who Require Inpatient Care

  NCT07364825· Brigham and Women's Hospital· Forrás

• Lezárult

  Efficacy and Safety of Magnesium Vitamin B6 in First Episode Bipolar Disorder

  NCT05837104· 2. fázis· Mclean Hospital· Forrás

• Lezárult

  PRISM Neurofeedback Training for MDD Anhedonic Patients

  NCT05869708· GrayMatters Health Ltd.· Forrás

• Lezárult

  SMART Trial to Predict Anhedonia Response to Antidepressant Treatment

  NCT05537584· 4. fázis· Mclean Hospital· Forrás

• Leállították

  A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease

  NCT05310071· 3. fázis· Biogen· Forrás

• Lezárult

  Community Reinforcement and Family Training for Early Psychosis (CRAFT-EP) and Substance Use: A Pilot Study

  NCT05380583· Mclean Hospital· Forrás

• Lezárult

  Effects of Nicotinamide Riboside on Bioenergetics and Oxidative Stress in Mild Cognitive Impairment/Alzheimer's Dementia

  NCT04430517· Korai 1. fázis· Mclean Hospital· Forrás

• Lezárult

  Electroconvulsive Therapy (ECT) for Agitation in Dementia (AD)

  NCT03926520· Brent Forester· Forrás

• Lezárult

  Behavioral and Electrophysiological Effects of Ketamine in Treatment-Resistant Depression

  NCT04239963· Mclean Hospital· Forrás

• Leállították

  A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205

  NCT04241068· 3. fázis· Biogen· Forrás

• Lezárult

  Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders

  NCT03943537· 2. fázis· Mclean Hospital· Forrás

• Lezárult

  Trial of Dronabinol Adjunctive Treatment of Agitation in Alzheimer's Disease

  NCT02792257· 2. fázis· Johns Hopkins University· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Skizofrénia71 munka · 13 vizsgálat
• Depresszió52 munka · 13 vizsgálat
• Bipoláris zavar39 munka · 12 vizsgálat